A bill introduced yesterday by Representative Maxine Waters, with support from the American Diabetes Association, would eliminate cost sharing for patients with diabetes requiring insulin amid the coronavirus disease 2019 pandemic; White House officials have decided to not release economic projections this summer for the first time since the 1970s; CDC provides recommendations for employers returning to the workplace.
Representative Maxine Waters, D-California, with support from the American Diabetes Association (ADA), introduced a bill yesterday that would allow all insulin-dependent Medicare beneficiaries to obtain their prescriptions for insulin and related medical supplies with no co-payment, coinsurance, deductibles, or other cost sharing for the remainder of the coronavirus disease 2019 (COVID-19) pandemic. Noted in a press release by the ADA, the organization called on all members of Congress to join the 25 original cosponsors of the bill, which would also ensure that Medicare beneficiaries can receive mail-in prescriptions for a 90-day supply. The move follows an announcement this week by CMS that would drop co-pays by 66% in 2021 for senior citizens who use insulin for diabetes and are enrolled in Medicare Advantage and certain Part D pharmaceutical plans, with co-pays additionally being capped at $35.
In an unprecedented move, White House officials have decided to not release updated economic projections this summer, which would highlight the severe economic decline caused by the COVID-19 pandemic. Reported by The Washington Post, the White House typically reveals a federal budget proposal every February that is then followed by a midsession review in July or August. However, its decision to opt against providing these updated projections, which include economic trends such as unemployment, inflation, and economic growth, would be the first time since at least the 1970s that these midsession forecasts were not published.
The CDC provided recommendations to US businesses returning to the workplace amid COVID-19, which include temperature and symptom checks at entry and 6 feet of distance between desks, according to The New York Times. The CDC says that if 6-feet distance is not possible, employers should consider attaching plastic shields around desks, and that face coverings should be worn at all times. The recommendations extend from technical advice on open windows to suggested removal of communal services such as latte makers and snack bins.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen